Wearable E-skin that can measure heart rate and blood pressure, and
paper diagnostic machines the size of a credit card that can give
instant readings on blood and saliva samples are two new bio-sensing
technologies presented at Elsevier’s 4th International Conference on
Bio-Sensing Technology in Lisbon, Portugal on 12 May 2015.
Bio-sensors can detect and analyze data to give patients information
on their heart rate and blood pressure, blood sugar and hormone levels,
and even test whether they are infected with antibiotic-resistant
bacteria. This detection technology is a step forward in personal
medicine, giving patients real-time information about how their bodies
are functioning and suggesting the most suitable treatments.
Professor Anthony Turner, Head of the Biosensors &
Bioelectronics Centre at Linköping University, Sweden, has developed an
instrument the size of a credit card that can analyse blood and saliva
samples. It is simple to use: you switch it on by pressing a button,
then apply your sample to a circle in the bottom right corner and wait
for a digital reading to be displayed and even sent to your mobile
phone.
The whole instrument is printed on the card using a screen-printing
technique. It could be used to monitor diabetes, kidney disease and
heart disease, or to detect cancer. This, says Professor Turner, could
turn a 2500-year-old paradigm on its head and put the power in the
patient’s hands.
“We’re on the cusp of an entirely new era – not just for
bio-sensing, but for measurements in healthcare and diagnostics
generally,” said Professor Turner. “Until now, we have been used to
going to a doctor, who endows us with some wisdom and retains
information about us, and then waiting to see if we get better. Modern
sensors and telecommunications are rebalancing this power; in the
future, patients could have the information, while physicians provide a
service.”
The printed instruments are the result of a collaboration between
Linköping University and Swedish ICT non-profit Acreo, and the team is
now looking for corporate partners to work with to mass-produce them. At
just €5 each – a cost that’s expected to fall to €0.50 – the paper
diagnostic instruments offer an inexpensive way to analyse samples.
“When I started doing electrochemistry 30 years ago, an instrument
like this would have been the size of a filing cabinet, and would have
cost me €10,000,” said Professor Turner. “We’ve now got the technology
figured out – we had to combine the area of printed electronics and
printed biosensors; it’s the first time anyone has printed an entire
instrument.”
This means they have the potential to provide patients and doctors
in developing countries with accessible, affordable medical tests. For
example, the printed card could be made part of the packaging of
antibiotics, helping determine which antibiotic would be best to treat a
patient’s infection.
Such printable devices could also be worn like plasters or contact
lenses, transmitting information to mobile phones. Similarly, e-skin
devices are also designed to be wearable and portable, and to transmit
data about how a patient’s body is functioning.
Professor Ting Zhang, from Suzhou Institute of Nano-Tech and
Nano-Bionics, Chinese Academy of Sciences, China, is presenting a new
kind of e-skin at the Conference. E-skin is developed based on flexible
electronic technology and nanotechnology; because of its unique ability
to detect tiny changes in pressure, e-skin can be used to monitor blood
pressure, heart rate and wrist pulse.
Professor Zhang and his team have developed two key aspects of the
technology – making the sensor element more sensitive and making the
material more flexible – bringing wearable diagnostic systems a step
closer. They have used carbon nanotubes and sheets of graphene only a
few atoms thick to construct ultra-sensitive, transparent and flexible
e-skin.
“We’re very excited to present our new technology,” said Professor
Zhang. “We’ve shown that the e-skin can be used to monitor many
different human physiological signals. We believe our new material can
give real-time diagnosis of diseases and provide an instant health
assessment while a patient is wearing it.”
Bio-sensing technologies are gaining momentum in areas like health,
the environment and security. The conference brings together leaders
from industry and academia to exchange and share their experiences,
present research results, explore collaborations and spark new ideas,
with the aim of developing new projects and exploiting new technology
for bio-sensing applications.
----
Presentation details:
“The Paper Potentiostat” by Professor Anthony Turner and “Flexible
Nanoelectronic Skin for Wearable/attachable Health Applications” by
Professor Ting Zhang are being presented on 12 May 2015 at Elsevier’s
4th International Conference on Bio-Sensing Technology in Lisbon,
Portugal.
About the 4th International Conference on Bio-Sensing Technology
Following the success of the first 3 conferences, the 4th
International Conference on Bio-Sensing Technology will continue to
bring together leaders from industry and academia to exchange and share
their experiences, present research results, explore collaborations and
to spark new ideas, with the aim of developing new projects and
exploiting new technology for bio-sensing applications.
About Elsevier
Elsevier is a world-leading provider of information solutions that
enhance the performance of science, health, and technology
professionals, empowering them to make better decisions, deliver better
care, and sometimes make groundbreaking discoveries that advance the
boundaries of knowledge and human progress. Elsevier provides web-based,
digital solutions — among them ScienceDirect, Scopus, Elsevier Research
Intelligence and ClinicalKey— and publishes over 2,500 journals,
including The Lancet and Cell, and more than 33,000 book titles,
including a number of iconic reference works. Elsevier is part of RELX
Group plc, a world-leading provider of information solutions for
professional customers across industries. www.elsevier.com